Charles Levenback, MD

The University of Texas MD Anderson Cancer Center

LevenbackDr. Levenback is Professor and Deputy Chair for Patient Care and the Gynecologic Oncology Center Medical Director in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center.

Dr. Levenback joined the faculty in 1989 after completing fellowship training at Memorial Sloan Kettering Cancer Center in New York City.  Dr. Levenback is recognized as a clinical leader as Deputy Chairman of the Department of Gynecologic Oncology and Reproductive Medicine as well as Medical Director of the Gynecologic Oncology Center.  He has been instrumental in doubling the size of the Gynecologic Oncology Center practice while incorporating strategies to improve clinical effectiveness and safety.  Dr. Levenback has received several M.D. Anderson recognition awards for his skill as an educator and communicator, and he is currently ranked as the Top Doctors for Gynecologic Oncology in U.S. News & World Report.  Dr. Levenback has an international reputation for the development of sentinel lymph node biopsy in patients with gynecologic cancer and serves as a member of several organizations, including the Board of Directors for The American College of Obstetricians and Gynecologists, the Steering Committee for the Council on Patient Safety in Women’s Health Care in Washington, DC, The Gynecologic Oncology Group Ovarian Committee and chairs the Surgery Safety Committee at M.D. Anderson Cancer Center.

Spotlight

SGO, ASCCP Clarify Recommendations of Primary HPV Testing for Cervical Cancer Screening. Read the release.

Awareness

We’re pleased to partner with the Dana Farber Cancer Institute to promote their recent webchat on cervical cancer treatment - watch now!

Research

The Foundation’s research award winners will be notified in January. Thank you to all who sent in their applications.

Education

The next Gynecologic Cancer Survivors Course is February 7-8 in Anchorage, Alaska. For more information, click here.